Press Release Department: 230422

The Canadian Myeloma Research Group (CMRG) is urging the pan-Canadian Pharmaceutical Alliance (pCPA) and Johnson & Johnson Innovative Medicine (JJIM) to return to the negotiating table after talks ended last week without agreeing to cover patient costs for Cilta-cel, a new therapy for patients with multiple myeloma. “Cilta-cel has shown unprecedented results for patients who have … Read more